nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—KCNH2—Sunitinib—pancreatic cancer	0.156	0.309	CbGbCtD
Terazosin—ABCB1—Tamoxifen—pancreatic cancer	0.0696	0.138	CbGbCtD
Terazosin—ABCB1—Gemcitabine—pancreatic cancer	0.0599	0.119	CbGbCtD
Terazosin—ABCB1—Erlotinib—pancreatic cancer	0.0592	0.117	CbGbCtD
Terazosin—ABCB1—Irinotecan—pancreatic cancer	0.0534	0.106	CbGbCtD
Terazosin—ABCB1—Docetaxel—pancreatic cancer	0.0392	0.0774	CbGbCtD
Terazosin—ABCB1—Sunitinib—pancreatic cancer	0.039	0.0771	CbGbCtD
Terazosin—ABCB1—Doxorubicin—pancreatic cancer	0.0292	0.0577	CbGbCtD
Terazosin—Face oedema—Doxorubicin—pancreatic cancer	0.000543	0.00134	CcSEcCtD
Terazosin—Malnutrition—Docetaxel—pancreatic cancer	0.000543	0.00134	CcSEcCtD
Terazosin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000542	0.00134	CcSEcCtD
Terazosin—Dyspepsia—Fluorouracil—pancreatic cancer	0.00054	0.00134	CcSEcCtD
Terazosin—Nausea—Tamoxifen—pancreatic cancer	0.000539	0.00134	CcSEcCtD
Terazosin—Fatigue—Gemcitabine—pancreatic cancer	0.000538	0.00133	CcSEcCtD
Terazosin—Gastritis—Epirubicin—pancreatic cancer	0.000538	0.00133	CcSEcCtD
Terazosin—Pain—Gemcitabine—pancreatic cancer	0.000534	0.00132	CcSEcCtD
Terazosin—Constipation—Gemcitabine—pancreatic cancer	0.000534	0.00132	CcSEcCtD
Terazosin—Nausea—Erlotinib—pancreatic cancer	0.000534	0.00132	CcSEcCtD
Terazosin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000533	0.00132	CcSEcCtD
Terazosin—Diarrhoea—Sunitinib—pancreatic cancer	0.000532	0.00132	CcSEcCtD
Terazosin—Dysgeusia—Docetaxel—pancreatic cancer	0.000531	0.00132	CcSEcCtD
Terazosin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000528	0.00131	CcSEcCtD
Terazosin—Asthma—Epirubicin—pancreatic cancer	0.000525	0.0013	CcSEcCtD
Terazosin—Influenza—Epirubicin—pancreatic cancer	0.000525	0.0013	CcSEcCtD
Terazosin—Back pain—Docetaxel—pancreatic cancer	0.000525	0.0013	CcSEcCtD
Terazosin—Pain—Fluorouracil—pancreatic cancer	0.000525	0.0013	CcSEcCtD
Terazosin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000524	0.0013	CcSEcCtD
Terazosin—Dizziness—Sunitinib—pancreatic cancer	0.000514	0.00127	CcSEcCtD
Terazosin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000514	0.00127	CcSEcCtD
Terazosin—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000514	0.00127	CcSEcCtD
Terazosin—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000512	0.00127	CcSEcCtD
Terazosin—Angina pectoris—Epirubicin—pancreatic cancer	0.000512	0.00127	CcSEcCtD
Terazosin—Abdominal pain—Irinotecan—pancreatic cancer	0.000506	0.00125	CcSEcCtD
Terazosin—Body temperature increased—Irinotecan—pancreatic cancer	0.000506	0.00125	CcSEcCtD
Terazosin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000506	0.00125	CcSEcCtD
Terazosin—Bronchitis—Epirubicin—pancreatic cancer	0.000505	0.00125	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000503	0.00124	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—pancreatic cancer	0.000498	0.00123	CcSEcCtD
Terazosin—Vomiting—Sunitinib—pancreatic cancer	0.000494	0.00122	CcSEcCtD
Terazosin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000493	0.00122	CcSEcCtD
Terazosin—Dysuria—Epirubicin—pancreatic cancer	0.000491	0.00122	CcSEcCtD
Terazosin—Rash—Sunitinib—pancreatic cancer	0.00049	0.00121	CcSEcCtD
Terazosin—Dermatitis—Sunitinib—pancreatic cancer	0.00049	0.00121	CcSEcCtD
Terazosin—Headache—Sunitinib—pancreatic cancer	0.000487	0.00121	CcSEcCtD
Terazosin—Syncope—Docetaxel—pancreatic cancer	0.000487	0.0012	CcSEcCtD
Terazosin—Asthma—Doxorubicin—pancreatic cancer	0.000486	0.0012	CcSEcCtD
Terazosin—Influenza—Doxorubicin—pancreatic cancer	0.000486	0.0012	CcSEcCtD
Terazosin—Pollakiuria—Epirubicin—pancreatic cancer	0.000485	0.0012	CcSEcCtD
Terazosin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000485	0.0012	CcSEcCtD
Terazosin—Palpitations—Docetaxel—pancreatic cancer	0.00048	0.00119	CcSEcCtD
Terazosin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000479	0.00119	CcSEcCtD
Terazosin—Weight increased—Epirubicin—pancreatic cancer	0.000478	0.00118	CcSEcCtD
Terazosin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000477	0.00118	CcSEcCtD
Terazosin—Cough—Docetaxel—pancreatic cancer	0.000474	0.00117	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—pancreatic cancer	0.000473	0.00117	CcSEcCtD
Terazosin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000472	0.00117	CcSEcCtD
Terazosin—Convulsion—Docetaxel—pancreatic cancer	0.00047	0.00116	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—pancreatic cancer	0.000467	0.00116	CcSEcCtD
Terazosin—Chest pain—Docetaxel—pancreatic cancer	0.000462	0.00114	CcSEcCtD
Terazosin—Arthralgia—Docetaxel—pancreatic cancer	0.000462	0.00114	CcSEcCtD
Terazosin—Myalgia—Docetaxel—pancreatic cancer	0.000462	0.00114	CcSEcCtD
Terazosin—Nausea—Sunitinib—pancreatic cancer	0.000462	0.00114	CcSEcCtD
Terazosin—Asthenia—Irinotecan—pancreatic cancer	0.00046	0.00114	CcSEcCtD
Terazosin—Jaundice—Epirubicin—pancreatic cancer	0.000457	0.00113	CcSEcCtD
Terazosin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000455	0.00113	CcSEcCtD
Terazosin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000455	0.00113	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—pancreatic cancer	0.000454	0.00112	CcSEcCtD
Terazosin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000452	0.00112	CcSEcCtD
Terazosin—Dry mouth—Docetaxel—pancreatic cancer	0.000452	0.00112	CcSEcCtD
Terazosin—Sweating—Epirubicin—pancreatic cancer	0.000449	0.00111	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—pancreatic cancer	0.000449	0.00111	CcSEcCtD
Terazosin—Asthenia—Gemcitabine—pancreatic cancer	0.000448	0.00111	CcSEcCtD
Terazosin—Confusional state—Docetaxel—pancreatic cancer	0.000447	0.00111	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000444	0.0011	CcSEcCtD
Terazosin—Oedema—Docetaxel—pancreatic cancer	0.000443	0.0011	CcSEcCtD
Terazosin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000443	0.0011	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—pancreatic cancer	0.000442	0.00109	CcSEcCtD
Terazosin—Epistaxis—Epirubicin—pancreatic cancer	0.000442	0.00109	CcSEcCtD
Terazosin—Pruritus—Gemcitabine—pancreatic cancer	0.000442	0.00109	CcSEcCtD
Terazosin—Sinusitis—Epirubicin—pancreatic cancer	0.000439	0.00109	CcSEcCtD
Terazosin—Diarrhoea—Irinotecan—pancreatic cancer	0.000438	0.00108	CcSEcCtD
Terazosin—Shock—Docetaxel—pancreatic cancer	0.000436	0.00108	CcSEcCtD
Terazosin—Pruritus—Fluorouracil—pancreatic cancer	0.000434	0.00107	CcSEcCtD
Terazosin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000434	0.00107	CcSEcCtD
Terazosin—Tachycardia—Docetaxel—pancreatic cancer	0.000432	0.00107	CcSEcCtD
Terazosin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000427	0.00106	CcSEcCtD
Terazosin—Dizziness—Irinotecan—pancreatic cancer	0.000424	0.00105	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—pancreatic cancer	0.000422	0.00105	CcSEcCtD
Terazosin—Anorexia—Docetaxel—pancreatic cancer	0.000422	0.00104	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—pancreatic cancer	0.000421	0.00104	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000421	0.00104	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000421	0.00104	CcSEcCtD
Terazosin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00042	0.00104	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—pancreatic cancer	0.000417	0.00103	CcSEcCtD
Terazosin—Sweating—Doxorubicin—pancreatic cancer	0.000415	0.00103	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000414	0.00103	CcSEcCtD
Terazosin—Hypotension—Docetaxel—pancreatic cancer	0.000414	0.00102	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—pancreatic cancer	0.000409	0.00101	CcSEcCtD
Terazosin—Vomiting—Irinotecan—pancreatic cancer	0.000407	0.00101	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—pancreatic cancer	0.000407	0.00101	CcSEcCtD
Terazosin—Dizziness—Fluorouracil—pancreatic cancer	0.000406	0.001	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—pancreatic cancer	0.000405	0.001	CcSEcCtD
Terazosin—Rash—Irinotecan—pancreatic cancer	0.000404	0.001	CcSEcCtD
Terazosin—Dermatitis—Irinotecan—pancreatic cancer	0.000404	0.000999	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000403	0.000999	CcSEcCtD
Terazosin—Headache—Irinotecan—pancreatic cancer	0.000401	0.000993	CcSEcCtD
Terazosin—Insomnia—Docetaxel—pancreatic cancer	0.000401	0.000991	CcSEcCtD
Terazosin—Paraesthesia—Docetaxel—pancreatic cancer	0.000398	0.000984	CcSEcCtD
Terazosin—Vomiting—Gemcitabine—pancreatic cancer	0.000397	0.000982	CcSEcCtD
Terazosin—Dyspnoea—Docetaxel—pancreatic cancer	0.000395	0.000977	CcSEcCtD
Terazosin—Somnolence—Docetaxel—pancreatic cancer	0.000394	0.000974	CcSEcCtD
Terazosin—Rash—Gemcitabine—pancreatic cancer	0.000393	0.000974	CcSEcCtD
Terazosin—Dermatitis—Gemcitabine—pancreatic cancer	0.000393	0.000973	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—pancreatic cancer	0.000393	0.000973	CcSEcCtD
Terazosin—Tinnitus—Epirubicin—pancreatic cancer	0.000392	0.00097	CcSEcCtD
Terazosin—Headache—Gemcitabine—pancreatic cancer	0.000391	0.000968	CcSEcCtD
Terazosin—Vomiting—Fluorouracil—pancreatic cancer	0.00039	0.000966	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—pancreatic cancer	0.00039	0.000965	CcSEcCtD
Terazosin—Dyspepsia—Docetaxel—pancreatic cancer	0.00039	0.000965	CcSEcCtD
Terazosin—Rash—Fluorouracil—pancreatic cancer	0.000387	0.000958	CcSEcCtD
Terazosin—Dermatitis—Fluorouracil—pancreatic cancer	0.000387	0.000957	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000386	0.000956	CcSEcCtD
Terazosin—Decreased appetite—Docetaxel—pancreatic cancer	0.000385	0.000953	CcSEcCtD
Terazosin—Headache—Fluorouracil—pancreatic cancer	0.000384	0.000951	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000383	0.000949	CcSEcCtD
Terazosin—Fatigue—Docetaxel—pancreatic cancer	0.000382	0.000945	CcSEcCtD
Terazosin—Nausea—Irinotecan—pancreatic cancer	0.000381	0.000942	CcSEcCtD
Terazosin—Pain—Docetaxel—pancreatic cancer	0.000379	0.000937	CcSEcCtD
Terazosin—Constipation—Docetaxel—pancreatic cancer	0.000379	0.000937	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—pancreatic cancer	0.000376	0.00093	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—pancreatic cancer	0.000375	0.000928	CcSEcCtD
Terazosin—Nausea—Gemcitabine—pancreatic cancer	0.000371	0.000917	CcSEcCtD
Terazosin—Malnutrition—Epirubicin—pancreatic cancer	0.000366	0.000906	CcSEcCtD
Terazosin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000365	0.000903	CcSEcCtD
Terazosin—Nausea—Fluorouracil—pancreatic cancer	0.000364	0.000902	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—pancreatic cancer	0.000364	0.0009	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—pancreatic cancer	0.000363	0.000898	CcSEcCtD
Terazosin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000362	0.000896	CcSEcCtD
Terazosin—Flatulence—Epirubicin—pancreatic cancer	0.000361	0.000893	CcSEcCtD
Terazosin—Tension—Epirubicin—pancreatic cancer	0.000359	0.000889	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—pancreatic cancer	0.000358	0.000887	CcSEcCtD
Terazosin—Nervousness—Epirubicin—pancreatic cancer	0.000355	0.00088	CcSEcCtD
Terazosin—Back pain—Epirubicin—pancreatic cancer	0.000354	0.000876	CcSEcCtD
Terazosin—Abdominal pain—Docetaxel—pancreatic cancer	0.00035	0.000867	CcSEcCtD
Terazosin—Body temperature increased—Docetaxel—pancreatic cancer	0.00035	0.000867	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000348	0.00086	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—pancreatic cancer	0.000345	0.000854	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00034	0.000841	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—pancreatic cancer	0.000339	0.000838	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—pancreatic cancer	0.000334	0.000826	CcSEcCtD
Terazosin—Tension—Doxorubicin—pancreatic cancer	0.000332	0.000823	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000332	0.000821	CcSEcCtD
Terazosin—Malaise—Epirubicin—pancreatic cancer	0.00033	0.000817	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—pancreatic cancer	0.000329	0.000814	CcSEcCtD
Terazosin—Vertigo—Epirubicin—pancreatic cancer	0.000329	0.000814	CcSEcCtD
Terazosin—Syncope—Epirubicin—pancreatic cancer	0.000328	0.000812	CcSEcCtD
Terazosin—Back pain—Doxorubicin—pancreatic cancer	0.000328	0.000811	CcSEcCtD
Terazosin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000326	0.000808	CcSEcCtD
Terazosin—Palpitations—Epirubicin—pancreatic cancer	0.000323	0.000801	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000322	0.000796	CcSEcCtD
Terazosin—Cough—Epirubicin—pancreatic cancer	0.000319	0.000791	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—pancreatic cancer	0.000319	0.00079	CcSEcCtD
Terazosin—Asthenia—Docetaxel—pancreatic cancer	0.000318	0.000786	CcSEcCtD
Terazosin—Convulsion—Epirubicin—pancreatic cancer	0.000317	0.000785	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000314	0.000778	CcSEcCtD
Terazosin—Pruritus—Docetaxel—pancreatic cancer	0.000313	0.000776	CcSEcCtD
Terazosin—Myalgia—Epirubicin—pancreatic cancer	0.000312	0.000771	CcSEcCtD
Terazosin—Chest pain—Epirubicin—pancreatic cancer	0.000312	0.000771	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—pancreatic cancer	0.000312	0.000771	CcSEcCtD
Terazosin—Anxiety—Epirubicin—pancreatic cancer	0.000311	0.000769	CcSEcCtD
Terazosin—Discomfort—Epirubicin—pancreatic cancer	0.000308	0.000762	CcSEcCtD
Terazosin—Malaise—Doxorubicin—pancreatic cancer	0.000305	0.000756	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—pancreatic cancer	0.000305	0.000754	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—pancreatic cancer	0.000304	0.000753	CcSEcCtD
Terazosin—Syncope—Doxorubicin—pancreatic cancer	0.000304	0.000752	CcSEcCtD
Terazosin—Diarrhoea—Docetaxel—pancreatic cancer	0.000303	0.00075	CcSEcCtD
Terazosin—Confusional state—Epirubicin—pancreatic cancer	0.000301	0.000745	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—pancreatic cancer	0.000299	0.000741	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000299	0.000739	CcSEcCtD
Terazosin—Oedema—Epirubicin—pancreatic cancer	0.000299	0.000739	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000298	0.000737	CcSEcCtD
Terazosin—Cough—Doxorubicin—pancreatic cancer	0.000296	0.000731	CcSEcCtD
Terazosin—Shock—Epirubicin—pancreatic cancer	0.000294	0.000727	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—pancreatic cancer	0.000293	0.000726	CcSEcCtD
Terazosin—Dizziness—Docetaxel—pancreatic cancer	0.000293	0.000725	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000292	0.000724	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—pancreatic cancer	0.000292	0.000722	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000289	0.000715	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—pancreatic cancer	0.000288	0.000714	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—pancreatic cancer	0.000288	0.000714	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—pancreatic cancer	0.000288	0.000714	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—pancreatic cancer	0.000287	0.000711	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—pancreatic cancer	0.000285	0.000705	CcSEcCtD
Terazosin—Anorexia—Epirubicin—pancreatic cancer	0.000285	0.000705	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—pancreatic cancer	0.000282	0.000698	CcSEcCtD
Terazosin—Vomiting—Docetaxel—pancreatic cancer	0.000282	0.000697	CcSEcCtD
Terazosin—Rash—Docetaxel—pancreatic cancer	0.000279	0.000691	CcSEcCtD
Terazosin—Hypotension—Epirubicin—pancreatic cancer	0.000279	0.000691	CcSEcCtD
Terazosin—Dermatitis—Docetaxel—pancreatic cancer	0.000279	0.000691	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—pancreatic cancer	0.000279	0.00069	CcSEcCtD
Terazosin—Headache—Docetaxel—pancreatic cancer	0.000277	0.000687	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000276	0.000684	CcSEcCtD
Terazosin—Oedema—Doxorubicin—pancreatic cancer	0.000276	0.000684	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000272	0.000674	CcSEcCtD
Terazosin—Shock—Doxorubicin—pancreatic cancer	0.000272	0.000673	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000271	0.00067	CcSEcCtD
Terazosin—Insomnia—Epirubicin—pancreatic cancer	0.00027	0.000669	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—pancreatic cancer	0.00027	0.000668	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—pancreatic cancer	0.000268	0.000664	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000267	0.000661	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—pancreatic cancer	0.000266	0.000659	CcSEcCtD
Terazosin—Somnolence—Epirubicin—pancreatic cancer	0.000266	0.000657	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—pancreatic cancer	0.000263	0.000652	CcSEcCtD
Terazosin—Nausea—Docetaxel—pancreatic cancer	0.000263	0.000651	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—pancreatic cancer	0.000263	0.000651	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—pancreatic cancer	0.00026	0.000643	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—pancreatic cancer	0.000258	0.000639	CcSEcCtD
Terazosin—Fatigue—Epirubicin—pancreatic cancer	0.000258	0.000637	CcSEcCtD
Terazosin—Constipation—Epirubicin—pancreatic cancer	0.000255	0.000632	CcSEcCtD
Terazosin—Pain—Epirubicin—pancreatic cancer	0.000255	0.000632	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000252	0.000623	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—pancreatic cancer	0.00025	0.000619	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000248	0.000614	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000246	0.00061	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000246	0.000609	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—pancreatic cancer	0.000246	0.000608	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000244	0.000605	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000243	0.000602	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—pancreatic cancer	0.00024	0.000595	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—pancreatic cancer	0.000238	0.00059	CcSEcCtD
Terazosin—Pain—Doxorubicin—pancreatic cancer	0.000236	0.000585	CcSEcCtD
Terazosin—Constipation—Doxorubicin—pancreatic cancer	0.000236	0.000585	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—pancreatic cancer	0.000236	0.000584	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—pancreatic cancer	0.000236	0.000584	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000228	0.000564	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000226	0.000559	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—pancreatic cancer	0.00022	0.000545	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000218	0.000541	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000218	0.000541	CcSEcCtD
Terazosin—Asthenia—Epirubicin—pancreatic cancer	0.000214	0.00053	CcSEcCtD
Terazosin—Pruritus—Epirubicin—pancreatic cancer	0.000211	0.000523	CcSEcCtD
Terazosin—Diarrhoea—Epirubicin—pancreatic cancer	0.000204	0.000506	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000204	0.000504	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—pancreatic cancer	0.000198	0.000491	CcSEcCtD
Terazosin—Dizziness—Epirubicin—pancreatic cancer	0.000198	0.000489	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—pancreatic cancer	0.000196	0.000484	CcSEcCtD
Terazosin—Vomiting—Epirubicin—pancreatic cancer	0.00019	0.00047	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000189	0.000468	CcSEcCtD
Terazosin—Rash—Epirubicin—pancreatic cancer	0.000188	0.000466	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—pancreatic cancer	0.000188	0.000466	CcSEcCtD
Terazosin—Headache—Epirubicin—pancreatic cancer	0.000187	0.000463	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—pancreatic cancer	0.000183	0.000452	CcSEcCtD
Terazosin—Nausea—Epirubicin—pancreatic cancer	0.000177	0.000439	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—pancreatic cancer	0.000176	0.000435	CcSEcCtD
Terazosin—Rash—Doxorubicin—pancreatic cancer	0.000174	0.000431	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—pancreatic cancer	0.000174	0.000431	CcSEcCtD
Terazosin—Headache—Doxorubicin—pancreatic cancer	0.000173	0.000429	CcSEcCtD
Terazosin—Nausea—Doxorubicin—pancreatic cancer	0.000164	0.000406	CcSEcCtD
Terazosin—ADRA1D—Signaling Pathways—JAG2—pancreatic cancer	5.64e-05	0.000624	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GCG—pancreatic cancer	5.63e-05	0.000623	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	5.63e-05	0.000622	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GAST—pancreatic cancer	5.57e-05	0.000616	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MEN1—pancreatic cancer	5.56e-05	0.000615	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	5.52e-05	0.00061	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AGTR1—pancreatic cancer	5.49e-05	0.000608	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PRSS1—pancreatic cancer	5.48e-05	0.000607	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	5.48e-05	0.000606	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DTX4—pancreatic cancer	5.41e-05	0.000598	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GLI1—pancreatic cancer	5.41e-05	0.000598	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AGTR1—pancreatic cancer	5.37e-05	0.000594	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	5.34e-05	0.00059	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SHH—pancreatic cancer	5.3e-05	0.000587	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CNR1—pancreatic cancer	5.3e-05	0.000586	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SCT—pancreatic cancer	5.28e-05	0.000584	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HEY1—pancreatic cancer	5.28e-05	0.000584	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOTCH4—pancreatic cancer	5.27e-05	0.000583	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PPP2R5B—pancreatic cancer	5.26e-05	0.000582	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NRP1—pancreatic cancer	5.26e-05	0.000582	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IAPP—pancreatic cancer	5.24e-05	0.000579	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	5.22e-05	0.000578	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GCG—pancreatic cancer	5.12e-05	0.000566	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	5.11e-05	0.000565	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	5.08e-05	0.000562	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HEY2—pancreatic cancer	5.06e-05	0.00056	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCK—pancreatic cancer	5.04e-05	0.000557	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	5.03e-05	0.000557	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTHLH—pancreatic cancer	5.03e-05	0.000556	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTCH1—pancreatic cancer	5.03e-05	0.000556	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	4.95e-05	0.000547	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CNR2—pancreatic cancer	4.91e-05	0.000543	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GLP1R—pancreatic cancer	4.91e-05	0.000543	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.91e-05	0.000543	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CXCL8—pancreatic cancer	4.91e-05	0.000543	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	4.9e-05	0.000542	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	4.88e-05	0.00054	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCKAR—pancreatic cancer	4.83e-05	0.000534	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ARG2—pancreatic cancer	4.75e-05	0.000526	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	4.69e-05	0.000519	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	4.69e-05	0.000519	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JAG2—pancreatic cancer	4.68e-05	0.000518	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MEN1—pancreatic cancer	4.61e-05	0.00051	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SST—pancreatic cancer	4.6e-05	0.000509	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	4.55e-05	0.000503	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.54e-05	0.000502	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	4.53e-05	0.000502	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—JAG1—pancreatic cancer	4.5e-05	0.000498	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOTCH3—pancreatic cancer	4.48e-05	0.000496	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	4.47e-05	0.000495	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	4.43e-05	0.00049	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SHH—pancreatic cancer	4.4e-05	0.000487	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH4—pancreatic cancer	4.37e-05	0.000484	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	4.36e-05	0.000482	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	4.36e-05	0.000482	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	4.36e-05	0.000482	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IAPP—pancreatic cancer	4.35e-05	0.000481	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	4.29e-05	0.000474	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CNR1—pancreatic cancer	4.24e-05	0.000469	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTHLH—pancreatic cancer	4.17e-05	0.000462	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTCH1—pancreatic cancer	4.17e-05	0.000462	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	4.16e-05	0.00046	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TYMP—pancreatic cancer	4.16e-05	0.00046	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CG—pancreatic cancer	4.12e-05	0.000456	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	4.1e-05	0.000453	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GCG—pancreatic cancer	4.1e-05	0.000453	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	4.08e-05	0.000451	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	4.07e-05	0.00045	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.99e-05	0.000441	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.99e-05	0.000441	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	3.91e-05	0.000433	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AGTR1—pancreatic cancer	3.91e-05	0.000433	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	3.89e-05	0.00043	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	3.86e-05	0.000427	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STK11—pancreatic cancer	3.85e-05	0.000426	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SST—pancreatic cancer	3.82e-05	0.000422	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.8e-05	0.00042	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.77e-05	0.000417	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.76e-05	0.000416	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JAG1—pancreatic cancer	3.74e-05	0.000413	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH3—pancreatic cancer	3.72e-05	0.000411	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	3.71e-05	0.00041	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	3.71e-05	0.00041	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CD—pancreatic cancer	3.62e-05	0.000401	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CNR1—pancreatic cancer	3.52e-05	0.00039	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.48e-05	0.000384	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.46e-05	0.000383	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CG—pancreatic cancer	3.42e-05	0.000378	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GCG—pancreatic cancer	3.4e-05	0.000376	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SST—pancreatic cancer	3.39e-05	0.000375	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SMAD4—pancreatic cancer	3.38e-05	0.000373	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GLP1R—pancreatic cancer	3.35e-05	0.000371	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.35e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.34e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL8—pancreatic cancer	3.34e-05	0.000369	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	3.32e-05	0.000367	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.31e-05	0.000366	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	3.3e-05	0.000365	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HES1—pancreatic cancer	3.3e-05	0.000365	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DPYD—pancreatic cancer	3.3e-05	0.000365	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AGTR1—pancreatic cancer	3.25e-05	0.000359	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STK11—pancreatic cancer	3.2e-05	0.000354	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CB—pancreatic cancer	3.16e-05	0.000349	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	3.13e-05	0.000346	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC2A2—pancreatic cancer	3.13e-05	0.000346	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	3.04e-05	0.000336	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL8—pancreatic cancer	3.03e-05	0.000336	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	3.02e-05	0.000334	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CD—pancreatic cancer	3.01e-05	0.000332	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.94e-05	0.000325	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TERT—pancreatic cancer	2.89e-05	0.000319	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.88e-05	0.000319	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	2.88e-05	0.000319	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	2.84e-05	0.000314	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.83e-05	0.000313	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SMAD4—pancreatic cancer	2.8e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL8—pancreatic cancer	2.77e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HIF1A—pancreatic cancer	2.76e-05	0.000306	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TSC2—pancreatic cancer	2.75e-05	0.000305	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HES1—pancreatic cancer	2.74e-05	0.000303	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—pancreatic cancer	2.7e-05	0.000298	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.67e-05	0.000295	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KDR—pancreatic cancer	2.64e-05	0.000292	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CB—pancreatic cancer	2.62e-05	0.00029	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.56e-05	0.000283	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL8—pancreatic cancer	2.52e-05	0.000278	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NFKBIA—pancreatic cancer	2.51e-05	0.000278	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	2.49e-05	0.000275	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOTCH1—pancreatic cancer	2.49e-05	0.000275	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	2.46e-05	0.000272	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CG—pancreatic cancer	2.43e-05	0.000269	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—NRAS—pancreatic cancer	2.43e-05	0.000269	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	2.43e-05	0.000269	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CD44—pancreatic cancer	2.42e-05	0.000268	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGF—pancreatic cancer	2.41e-05	0.000266	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TERT—pancreatic cancer	2.4e-05	0.000265	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.33e-05	0.000257	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GCG—pancreatic cancer	2.32e-05	0.000257	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HIF1A—pancreatic cancer	2.29e-05	0.000254	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TSC2—pancreatic cancer	2.29e-05	0.000253	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—pancreatic cancer	2.24e-05	0.000248	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	2.24e-05	0.000247	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—EGFR—pancreatic cancer	2.22e-05	0.000245	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KDR—pancreatic cancer	2.19e-05	0.000243	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—STK11—pancreatic cancer	2.18e-05	0.000241	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CD—pancreatic cancer	2.14e-05	0.000237	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	2.13e-05	0.000236	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.12e-05	0.000234	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—KRAS—pancreatic cancer	2.09e-05	0.000232	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NFKBIA—pancreatic cancer	2.09e-05	0.000231	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH1—pancreatic cancer	2.07e-05	0.000228	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	2.04e-05	0.000225	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	2.03e-05	0.000225	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CG—pancreatic cancer	2.02e-05	0.000223	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—NRAS—pancreatic cancer	2.02e-05	0.000223	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGF—pancreatic cancer	2e-05	0.000221	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	1.99e-05	0.00022	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	1.95e-05	0.000215	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CA—pancreatic cancer	1.92e-05	0.000213	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TYMS—pancreatic cancer	1.88e-05	0.000208	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CB—pancreatic cancer	1.86e-05	0.000206	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.85e-05	0.000205	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	1.84e-05	0.000204	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.83e-05	0.000203	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	1.79e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	1.79e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL8—pancreatic cancer	1.79e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HRAS—pancreatic cancer	1.78e-05	0.000197	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	1.78e-05	0.000196	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	1.77e-05	0.000196	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.76e-05	0.000195	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	1.74e-05	0.000192	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	1.73e-05	0.000191	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	1.71e-05	0.00019	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	1.67e-05	0.000185	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	1.65e-05	0.000183	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	1.63e-05	0.000181	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	1.62e-05	0.000179	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	1.61e-05	0.000178	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.6e-05	0.000177	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	1.58e-05	0.000174	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	1.57e-05	0.000174	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.56e-05	0.000173	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	1.55e-05	0.000171	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	1.54e-05	0.000171	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—pancreatic cancer	1.53e-05	0.000169	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	1.49e-05	0.000165	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	1.49e-05	0.000164	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	1.48e-05	0.000163	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	1.46e-05	0.000161	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	1.44e-05	0.000159	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	1.44e-05	0.000159	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	1.44e-05	0.000159	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	1.42e-05	0.000157	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.42e-05	0.000157	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	1.39e-05	0.000153	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.38e-05	0.000152	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.37e-05	0.000152	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	1.37e-05	0.000152	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	1.34e-05	0.000149	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	1.34e-05	0.000148	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	1.34e-05	0.000148	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	1.34e-05	0.000148	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—pancreatic cancer	1.33e-05	0.000147	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	1.32e-05	0.000146	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.31e-05	0.000145	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	1.31e-05	0.000145	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	1.3e-05	0.000144	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.28e-05	0.000141	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.26e-05	0.00014	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	1.24e-05	0.000137	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	1.24e-05	0.000137	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.23e-05	0.000136	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.22e-05	0.000135	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.21e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	1.21e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	1.2e-05	0.000132	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.19e-05	0.000132	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	1.19e-05	0.000132	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.19e-05	0.000131	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.16e-05	0.000128	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	1.14e-05	0.000126	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	1.11e-05	0.000123	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	1.11e-05	0.000123	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.1e-05	0.000122	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	1.1e-05	0.000122	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	1.09e-05	0.00012	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.07e-05	0.000119	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.06e-05	0.000118	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.06e-05	0.000117	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.06e-05	0.000117	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	1.05e-05	0.000116	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.05e-05	0.000116	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	1.03e-05	0.000114	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	9.87e-06	0.000109	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	9.85e-06	0.000109	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	9.65e-06	0.000107	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	9.43e-06	0.000104	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	9.28e-06	0.000103	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTEN—pancreatic cancer	9.13e-06	0.000101	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	9.13e-06	0.000101	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	9.12e-06	0.000101	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	8.73e-06	9.65e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	8.38e-06	9.27e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	8.11e-06	8.97e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	7.75e-06	8.58e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	7.71e-06	8.52e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	6.84e-06	7.57e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	6.44e-06	7.12e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—pancreatic cancer	5.26e-06	5.82e-05	CbGpPWpGaD
